Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein

By Tachibana T.   Kato M.   Watanabe T.   Mitsui T.   Sugiyama Y.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 430-443

Informa Healthcare

Access to resources Recommend Favorite

Endotoxin Downregulates Hepatic Expression of P-Glycoprotein and MRP2 in 2-Acetylaminofluorene-Treated Rats

By Tang W.   Yi C.   Kalitsky J.   Piquette-Miller M.  

Molecular Cell Biology Research Communications, Vol. 4, Iss. 2, 2000-08 ,pp. : 90-97

Academic Press

Access to resources Recommend Favorite

Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats

By Kanazu T.   Yamaguchi Y.   Okamura N.   Baba T.   Koike M.  

Xenobiotica, Vol. 34, Iss. 5, 2004-05 ,pp. : 403-413

Informa Healthcare

Access to resources Recommend Favorite

Modulation of MDR1 and CYP3A Expression by Dexamethasone: Evidence for an Inverse Regulation in Adrenals

By Sérée E.   Villard P.H.   Hevér A.   Guigal N.   Puyoou F.   Charvet B.   Point-Scomma H.   Lechevalier E.   Lacarelle B.   Barra Y.  

Biochemical and Biophysical Research Communications, Vol. 252, Iss. 2, 1998-11 ,pp. : 392-395

Elsevier

Access to resources Recommend Favorite

Cloning and Functional Expression of a First Inducible Avian Cytochrome P450 of the CYP3A Subfamily (CYP3A37)

By Ourlin J-C.   Baader M.   Fraser D.   Halpert J.R.   Meyer U.A.  

Archives of Biochemistry and Biophysics, Vol. 373, Iss. 2, 2000-01 ,pp. : 375-384

Elsevier

Access to resources Recommend Favorite